{"id":"W2946986050","doi":"10.1016/j.clgc.2019.05.012","title":"Disease Characteristics and Completion of Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Radium-223 in an International Early Access Program","year":2019,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal","funders":"Pfizer Canada; Bristol-Myers Squibb Canada; Orionin Tutkimussäätiö; Cilag; Astellas Pharma; Ipsen; Astellas Pharma Canada; Bristol-Myers Squibb; Bayer Corporation; Janssen Canada; Meso Scale Diagnostics; Sanofi; Roche; Novartis; Amgen; Pfizer; Johnson and Johnson; Takeda Pharmaceutical Company; Active Biotech; Bayer","keywords":"Medicine; Prostate cancer; Radium-223; Oncology; Disease; Internal medicine; Radium; Castration; Urology; Cancer; Hormone; Bone metastasis","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001043524,0.0002042234,0.0004777197,0.0001546935,0.00002543585,0.00004201413,0.00009190477,0.00004292216,0.00008867092],"category_scores_gemma":[0.00001091546,0.000129087,0.00004114718,0.0002438011,0.0001710895,0.0002974572,0.00003079565,0.0001591976,0.000001485442],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004152788,"about_ca_system_score_gemma":0.0005525158,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001150314,"about_ca_topic_score_gemma":0.0006316497,"domain_scores_codex":[0.9984125,0.0001057213,0.0004902075,0.0004305752,0.0003049877,0.0002559397],"domain_scores_gemma":[0.9990457,0.00006299248,0.0001902429,0.0002206278,0.0002437767,0.0002366181],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02918195,0.003388545,0.944522,0.0001469781,0.0001964212,0.000170101,0.0001511198,0.00004857058,0.00006658785,0.000001705465,0.000003420804,0.02212261],"study_design_scores_gemma":[0.01754428,0.009111355,0.9719754,0.0004154741,0.0001449375,9.411351e-7,0.00003265295,0.000445836,0.00005280681,0.000003390882,0.0001284582,0.0001444464],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962555,0.0001932247,4.424035e-7,0.0002470055,0.00008059125,0.002797252,0.000371878,0.00001776649,0.00003633604],"genre_scores_gemma":[0.9973227,0.0008748964,0.0001511452,0.00003309863,0.00006516492,0.0007367511,0.0005065618,0.00002704169,0.0002825987],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02745343,"threshold_uncertainty_score":0.5264015,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06678858482934684,"score_gpt":0.420381723733961,"score_spread":0.3535931389046141,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}